Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategies.

ABSTRACT:

Introduction

Knowledge of the contemporary epidemiology of hepatitis B virus (HBV) infection among military personnel can inform potential Department of Defense (DoD) screening policy and infection and disease control strategies.

Materials and methods

HBV infection status at accession and following deployment was determined by evaluating reposed serum from 10,000 service members recently deployed to combat operations in Iraq and Afghanistan in the period from 2007 to 2010. A cost model was developed from the perspective of the Department of Defense for a program to integrate HBV infection screening of applicants for military service into the existing screening program of screening new accessions for vaccine-preventable infections.

Results

The prevalence of chronic HBV

SUBMITTER: Scott PT 

PROVIDER: S-EPMC7526854 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature